ADAM28

ADAM28 occupies a distinctive niche at the intersection of immunology and hemostasis. It is expressed mainly in lymphoid tissues and cells, including lymph node, thymus, lymphocyte subsets and eosinophils, and additionally appears in some epithelial tumors. Functionally, ADAM28 cleaves von Willebrand factor, providing a proteolytic pathway parallel to ADAMTS13 for controlling the multimer size of this hemostatic protein, and it also modulates IGF signaling through cleavage of IGFBP-3. Elevated expression in eosinophils has connected the enzyme with bronchial asthma, and ADAM28 overexpression is documented in breast carcinoma, prompting interest as a disease marker.